Dec 31, 2020 10:52 AM (GMT+8) · EqualOcean
The first batch of centralized procurement results of national organization consumables (coronary stents) will be officially implemented from January 1, 2021. Patients in Beijing will use high-quality and low-cost medical products. Ten products of eight enterprises were selected in this centralized procurement. Among them, 7 products from domestic enterprises, 3 products from foreign-funded enterprises, and several mainstream products commonly used in clinic were selected successfully. Compared with the original purchase price, the average price of drug loaded alloy coronary stent decreased from about 13000 yuan to about 700 yuan, and the average price of the selected stent decreased by more than 90%.